feedback

Faculty

Michael E. Manning
Michael E. Manning, MD, FAAAAI, FACAAI

President/Medical Director
Medical Research of Arizona
Allergy, Asthma & Immunology Associates, Ltd.
Scottsdale, Arizona

Luz Fonacier
Luz Fonacier, MD, FAAAAI, FACAAI

Professor of Medicine, State University of
New York at Stony Brook
Stony Brook, New York
Head of Allergy
Program Director of Allergy and
Immunology Fellowship Program

Winthrop-University Hospital
Mineola, New York

Richard G. Gower
Richard G. Gower, MD, FACAAI, FAAAAI, FACP

Past Clinical Associate Professor of Medicine
University of Washington School of Medicine
Principal Investigator
Marycliff Clinical Research
Spokane, Washington

Jointly Provided By

Activity Details

Credit Type: AMA PRA Category 1 Credit
Credit Amount: 1.0 AMA PRA Category 1 Credit(s)™
Release Date: December 6, 2016
Expiration Date: December 6, 2017
Estimated Time to Complete Activity: 1 hour
Registration Required: No
Fee for Activity: There is no fee for this educational activity.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Formulate an appropriate diagnostic workup for symptomatology suggestive of chronic urticaria (CU), taking into account the potential differential diagnosis
  2. Screen for and assess quality of life issues in patients with CU
  3. Incorporate into practice evidence-based treatment options and guidelines for managing CU that maximize efficacy while minimizing adverse effects
  4. Utilize the principles of patient engagement and shared decision making to implement strategies for effective management of quality of life issues in patients with CU

Target Audience

This activity has been designed to meet the educational needs of allergists/ immunologists, dermatologists, and primary care clinicians who manage patients with chronic urticaria (CU).

Requirements for Successful Completion

75%

Media

Internet

Disclosure Of Conflicts Of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Michael E. Manning, MD, FAAAAI, FACAAI, has affiliations with Genentech (Non-CME/CE Services); and Novartis Pharmaceuticals Corporation (Contracted Research).
  • Luz Fonacier, MD, FAAAAI, FACAAI, has affiliations with Church and Dwight, Co., Regeneron (Consulting Fees); and Genentech, Merck (Contracted Research).
  • Richard G. Gower, MD, FACAAI, FAAAAI, FACP, has affiliations with Genentech (Consulting Fees); and Genentech, Novartis Pharmaceuticals Corporation (Non-CME/CE Services and Contracted Research).

RMEI Medical Education, LLC

  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Nora Hartley has no affiliations with commercial interests relative to the content to disclose.

Postgraduate Institute for Medicine

The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

Statement of Commercial Support

This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC. This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.